Transcript Module D-1 Outpatient 2013

Module D
OUTBREAKS AND SAFE INJECTION
PRACTICES IN OUTPATIENT SETTINGS
OUTLINE
1.
The big picture
2.
Outbreaks and best practices
3.
Beyond the outbreaks
4.
Resources
THE BIG PICTURE
THE BIG PICTURE
UNSAFE INJECTION PRACTICES HAVE
DEVASTATING CONSEQUENCES
UNSAFE INJECTION-RELATED OUTBREAKS SINCE 2001
• 48 recognized outbreaks
• Viral hepatitis (n=21) or bacterial infections (n=27)
• 90% (n=43) occurred in outpatient settings
• 10 in pain management clinics
• 9 in outpatient oncology clinics
• >150,000 patients potentially exposed
*CDC Grand Rounds 11/14/12 & Guh et al, Medical Care 2012
HEPATITIS B VIRUS OUTBREAKS RELATED TO
BLOOD GLUCOSE MONITORING, 2001-2011
• 23 recognized outbreaks due to the assisted
monitoring of blood glucose (AMBG)
•
~2,000 notifications
• >170 incident infections
• Accounted for 92% of all hepatitis B virus
outbreaks in long term care facilities
*Thompson et al, Annals Int Med 2009; www.cdc.gov/hepatitis/Outbreaks
NC EXPERIENCE, 2001 - 2012
Incident
Infections
(n)
Lapse
11
ABGM
5
Syringe Reuse
Contaminating
MDV
Strengthened
.0206
8
ABGM
6/8 patients died,
“Act to Protect
Adult Care Home
Residents”
hepatit
is B
116
virus
6
Unknown
hepatit
is B
109
virus
6
ABGM
Exposed
(n)
Year
Setting
Type
2003
Nursing
Home
hepatit
is B
192
virus
2008
Cardiology
Clinic
hepatit
is C
1200
virus
2010
Assisted-living
Facility
hepatit
is B
87
virus
2010
Skilled Nursing
Facility
2010
Skilled Nursing
Facility
ABGM – Assisted Blood Glucose Monitoring
Note
OUTBREAK CAUSES &
BEST PRACTICES
OUTBREAK CAUSES
1. Syringe reuse (direct and indirect)
2. Misuse of single-dose/single-use vials
3. Failure to use aseptic technique
4. Unsafe diabetes care
SYRINGE REUSE
• Direct Reuse
• Insulin pens, IV tubing, vaccines
• Indirect Reuse or “double dipping”
• Common cause of large hepatitis outbreaks
• Syringe that had been used to inject medication into a
patient and reused to enter a medication vial
• Contents of the vial are then used for subsequent
patients
ENDOSCOPY CENTER, NEVADA (2008)
•
9 clinic-associated hepatitis C virus cases
•
106 possible clinic-associated cases
•
63,000 potential exposures
•
$16–21 million total cost
THE NEVADA OUTBREAK: MECHANISM
Two breaches contributed to transmission:
•
Re-entering propofol vials with used syringes
•
Using contents from these single-dose vials on
more than one patient
MMWR 2008 57(19);513-517
DANGEROUS MISPERCEPTIONS
1. Changing the needle makes a syringe safe for reuse.
2. Syringes can be reused as long as an injection is
administered through an intervening length of IV tubing.
3. If you don't see blood in the IV tubing or syringe, it
means that those supplies are safe for reuse.
Once they are used, both the needle and syringe are
contaminated and must be discarded!
2. MISUSE OF SINGLE-DOSE/SINGLE-USE VIALS
(SINGLE DOSE VIAL)
• CDC is aware of at least 19 outbreaks involving
single dose vial use
• 7 outbreaks involved BBPs
• 12 involved bacterial infections (majority of patients
requiring hospitalization)
• All outbreaks occurred in outpatient settings
• Almost half in pain remediation clinics (n=8)
INVASIVE S. AUREUS INFECTIONS ASSOCIATED WITH PAIN
INJECTIONS AND REUSE OF SINGLE DOSE VIAL – ARIZONA
AND DELAWARE, 2012
Clinic Type
Suspected Breaches
Outcomes
Pain Clinic
(AZ)
 Prepared ‘morning’ and ‘afternoon’
contrast solution from single dose
vials at start of day for multiple
patients
 Failed to wear facemasks during
spinal injections
 3 MRSA infections among patients
receiving ‘afternoon’ solution
 All patients hospitalized, ranging
from 4-41 days
 1 additional patient found deceased
in home; invasive MRSA could not be
ruled out
 single dose vial accessed over the
course of several hours for multiple
patients until all contents were
withdrawn
 7 methicillin-susceptible S. aureus
infections
 All patients required debridement of
infected sites and antimicrobial
therapy
 Average length of hospitalization was
6 days
Orthopedic
Clinic
(DE)
Invasive Staphylococcus aureus Infections Associated with Pain Injections and Reuse of Single-Dose Vials, Arizona and
Delaware, 2012; Morbidity & Mortality Weekly Report. 2012;61(27):501-504
SINGLE DOSE VIALS:
CDC POSITION STATEMENT, 2012
• Vials labeled by the manufacturer as “single dose” or “single
use” should only be used for a single patient.
• Ongoing outbreaks provide ample evidence that inappropriate
use of single-dose/single-use vials causes patient harm.
• Leftover parenteral medications should never be pooled for
later administration
• In times of critical need, contents from unopened single dose vials can
be repackaged for multiple patients in accordance with standards in
United States Pharmacopeia General Chapter ‹797›
www.cdc.gov/injectionsafety/CDCposition-SingleUseVial.html
3. FAILURE TO USE ASEPTIC TECHNIQUE
Handling and preparing supplies
used for injections in a manner
that prevents microbial
contamination between the
injection materials and the nonsterile environment
American Journal of Infection Prevention, 2011
18
NEW JERSEY – ONCOLOGY OFFICE
Single use vials stored and
used on subsequent days
for multiple patients
NEW JERSEY – ONCOLOGY OFFICE
IV bags used as
sources of fluid to
flush catheters for
multiple patients
IV bags with
stoppers removed
NEW JERSEY – ONCOLOGY OFFICE
Medication prepared in
hood in patient
treatment area
Medication prepared in
advance
Blood drawing
equipment in area of
medication
preparation
Uncapped syringes for
flushing IVs
unwrapped and
prefilled in advance
NEW JERSEY – ONCOLOGY OFFICE
Reused Vacutainer
holders in contact
with gauze
Blood
contamination
4. UNSAFE DIABETES CARE
Use of fingerstick
devices or insulin pens
on multiple persons
Sharing of blood
glucose meters
without cleaning and
disinfection between
uses
Failure to perform
hand hygiene or
change gloves
between procedures
Patel et al. ICHE 2009; 30:209-14,Thompson et al. JAGS 2010, MMWR 2005; 54:220-3
UNSAFE INJECTIONS: CAUSES & BEST PRACTICES
1. Syringe reuse (direct and indirect)
• Never administer medications from the same syringe to
multiple patients
• Do not reuse a syringe to enter a medication vial or
solution
• Limit the use of multi-dose vials and dedicate them to a
single patient whenever possible
2. Misuse of single-dose/single-use vials
• Do not administer medications from a single dose vial or
IV solution bag to more than one patient
UNSAFE INJECTIONS: CAUSES AND BEST PRACTICES
3. Failure to use aseptic technique
• Use aseptic technique when preparing or
administering medications
4. Unsafe diabetes care
• Use insulin pens and lancing devices for only one
patient
• Dedicate glucometers to a single patient. If they
MUST be shared, clean and disinfect after each use
BEYOND OUTBREAKS
MOST OUTBREAKS ARE NEVER DETECTED
Asymptomatic
infection
Under-reporting of
cases
Under-recognition of
healthcare as risk
Long incubation
period;
difficult to identify
single healthcare
exposure
Barriers to
investigation,
resource constraints
ROLE OF HEALTHCARE-ASSOCIATED
TRANSMISSION: BEYOND OUTBREAKS
• Among patients ≥55:
• Those with acute hepatitis B virus or hepatitis C
virus are 2.7x more likely to report having had
injections in a health care setting
• Approximately 37% of acute hepatitis B virus
and hepatitis C virus infections attributable to
unsafe injections in health care settings
Perz et al, Hepatology 2012.‘Accepted Article’, doi: 10.1002/hep.25688
GROWING RESERVOIR
•
Aging population – more frequent interactions with
the healthcare system
•
“…growing reservoir of infected
individuals who can serve as a
source of transmission to others
if safe injection practices and
other basic infection control
precautions are not followed”
Perz et al, Hepatology 2012.‘Accepted Article’, doi: 10.1002/hep.25688
2010 SURVEY OF PROVIDER PRACTICES
5,500 healthcare professionals
•
1% “sometimes or always” reuse a syringe on a
second patient (direct)
•
1% “sometimes or always” reuse a multidose vial
after accessing it with a reused syringe (indirect)
•
6% use single-dose/single use vials for more than
one patient
Pugliese et al 2010. AJIC. Available at: http://www.cdc.gov/injectionsafety or
http://www.ajicjournal.org/article/PIIS0196655310008539/abstract
WHY ARE WE MISSING THE MARK?
• Knowledge Gaps
• Poor training
• Lax or nonexistent policies and procedures
• Knowledge not translated into practice
• Drug shortages
• Economic/time pressure
• Malfeasance
• Drug Diversion
KNOW AND PRACTICE THESE SIMPLE
RULES
Safe injections
Safe diabetes care
• Needles and syringes are single use
devices. They should not be used
for more than one patient or
reused to draw up additional
medication.
• Fingerstick devices should never be
used for more than one person.
• Do not administer medications
from a single-dose vial or IV bag to
multiple patients.
• Limit the use of multi-dose vials
and dedicate them to a single
patient whenever possible.
• Blood glucose meters should be
assigned to an individual person.
•
If shared, it must be cleaned and
disinfected per manufacturer’s
instructions
• Injection equipment (e.g., insulin
pens, needles and syringes) should
never be used for more than one
person.
BEYOND GOOD PRACTICE
• Designate someone to provide ongoing oversight
• Develop written infection control policies
• Provide training
• Conduct quality assurance assessments
WWW.ONEANDONLYCAMPAIGN.ORG
ACKNOWLEDGMENTS
Slides adapted from the following sources:

Perz J, Patel PR, Srinivasan A. A “Never” Event: Unsafe Injection Practices.
www.emergency.cdc.gov/
coca/ppt/UnsafeInjectionPractices032708.ppt

Shaefer M. Injection Safety. Presented at APIC North Carolina Fall
Education Conference October 5, 2009, Durham, NC.

Perz J and Thompson N. Viral hepatitis exposure & public health response.
Presented at NACCHO Toolkit Development Workshop January 7, 2009 Las
Vegas, NV

Perz, CDC Public Health Grand Rounds, 11/14/12

Montana, B. Keeping the Infection out of Injection. NJ Department of
Health and Senior Services

Moore, Zack. Various Slides. NC DHHS.